Ubiquitin-like with PHD and ring finger domains 2 is a predictor of survival and a potential therapeutic target in colon cancer

Lu,Su; Yan,Dongwang; Wu,Zehua; Jiang,Tao; Chen,Jian; Yuan,Lin; Lin,Jun; Peng,Zhihai; Tang,Huamei

doi:10.3892/or.2014.3035

2014-April Volume 31 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

2014-April Volume 31 Issue 4

Full Size Image

Article

Ubiquitin-like with PHD and ring finger domains 2 is a predictor of survival and a potential therapeutic target in colon cancer

Authors:
- Su Lu
- Dongwang Yan
- Zehua Wu
- Tao Jiang
- Jian Chen
- Lin Yuan
- Jun Lin
- Zhihai Peng
- Huamei Tang
View Affiliations / Copyright

Affiliations: Department of Pathology, Shanghai Jiaotong University Affiliated First People's Hospital, Shanghai 200080, P.R. China, Department of General Surgery, Shanghai Jiaotong University Affiliated First People's Hospital, Shanghai 200080, P.R. China
Pages: 1802-1810
|
Published online on: February 19, 2014

https://doi.org/10.3892/or.2014.3035
Expand metrics +

Abstract

In the present study, we investigated the expression of ubiquitin-like with PHD and ring finger domains 2 (UHRF2) in colon cancer and adjacent normal tissues and estimated the clinicopathological significance and predictive value of UHRF2 expression in colon cancer. Using quantitative real-time PCR, tissue microarray (TMA), western blot analysis and immunohistochemical staining, we evaluated UHRF2 mRNA and protein levels in tumor tissues and paired adjacent normal epithelium. We found that UHRF2 was upregulated at both the transcriptional and translational levels in tumor tissues. Immunohistochemical detection of UHRF2 on a TMA containing 203 paired specimens showed that increased cytoplasmic UHRF2 was significantly associated with clinical stage, depth of invasion, nodal involvement, tumor histologic grade and the presence of metastasis. Patients with UHRF2-positive tumors had a much lower disease-free survival [hazard ratio (HR) 9.511, P<0.001] and overall survival (HR 9.820, P<0.001). Univariate and multivariate analyses were performed to determine the correlation between these parameters and the clinical and pathological variables of the study population verifying that UHRF2 immunoreactivity emerged as an independent prognostic factor in the multivariate analysis. UHRF2 may contribute to the progression of colon carcinogenesis and function as a novel prognostic indicator after curative operation.

View Figures

View References

1	Vogelstein B and Kinzler KW: Cancer genes and the pathways they control. Nat Med. 10:789–799. 2004. View Article : Google Scholar : PubMed/NCBI
2	Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
3	Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249. 2009. View Article : Google Scholar
4	Zhang S, Cui Y, Weng Z, Gong X, Chen M and Zhong B: Changes on the disease pattern of primary colorectal cancers in Southern China: a retrospective study of 20 years. Int J Colorectal Dis. 24:943–949. 2009.PubMed/NCBI
5	Petrova TV, Nykänen A, Norrmén C, et al: Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. Cancer Cell. 13:407–419. 2008. View Article : Google Scholar : PubMed/NCBI
6	Sansom OJ, Meniel VS, Muncan V, et al: Myc deletion rescues Apc deficiency in the small intestine. Nature. 446:676–679. 2007. View Article : Google Scholar
7	Micel LN, Tentler JJ, Smith PG and Eckhardt GS: Role of ubiquitin ligases and the proteasome in oncogenesis: novel targets for anticancer therapies. J Clin Oncol. 31:1231–1238. 2013. View Article : Google Scholar : PubMed/NCBI
8	Bedford L, Lowe J, Dick LR, Mayer RJ and Brownell JE: Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov. 10:29–46. 2011. View Article : Google Scholar : PubMed/NCBI
9	Reinstein E and Ciechanover A: Narrative review: protein degradation and human diseases: the ubiquitin connection. Ann Intern Med. 145:676–684. 2006. View Article : Google Scholar : PubMed/NCBI
10	Naujokat C and Sarić T: Concise review: role and function of the ubiquitin-proteasome system in mammalian stem and progenitor cells. Stem Cells. 25:2408–2418. 2007. View Article : Google Scholar : PubMed/NCBI
11	Bronner C, Achour M, Arima Y, Chataigneau T, Saya H and Schini-Kerth VB: The UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol Ther. 115:419–434. 2007. View Article : Google Scholar : PubMed/NCBI
12	Hopfner R, Mousli M, Jeltsch JM, et al: ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIα expression. Cancer Res. 60:121–128. 2000.
13	Mori T, Li Y, Hata H, Ono K and Kochi H: NIRF, a novel RING finger protein, is involved in cell-cycle regulation. Biochem Biophys Res Commun. 296:530–536. 2002. View Article : Google Scholar : PubMed/NCBI
14	Kotliarov Y, Steed ME, Christopher N, et al: High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. Cancer Res. 66:9428–9436. 2006. View Article : Google Scholar : PubMed/NCBI
15	Wu J, Liu S, Liu G, et al: Identification and functional analysis of 9p24 amplified genes in human breast cancer. Oncogene. 31:333–341. 2012. View Article : Google Scholar : PubMed/NCBI
16	Li DW, Tang HM, Fan JW, et al: Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer. J Cancer Res Clin Oncol. 136:997–1006. 2010. View Article : Google Scholar : PubMed/NCBI
17	Yan DW, Fan JW, Yu ZH, et al: Downregulation of metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue. Biochim Biophys Acta. 1822:918–926. 2012. View Article : Google Scholar : PubMed/NCBI
18	Troup S, Njue C, Kliewer EV, et al: Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res. 9:207–214. 2003.PubMed/NCBI
19	Bachmann IM, Puntervoll HE, Otte AP and Akslen LA: Loss of BMI-1 expression is associated with clinical progress of malignant melanoma. Mod Pathol. 21:583–590. 2008. View Article : Google Scholar : PubMed/NCBI
20	Hashimoto Y, Skacel M, Lavery IC, Mukherjee AL, Casey G and Adams JC: Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas. BMC Cancer. 6:2412006. View Article : Google Scholar : PubMed/NCBI
21	Lorenzato M, Caudroy S, Bronner C, et al: Cell cycle and/or proliferation markers: what is the best method to discriminate cervical high-grade lesions? Hum Patho. 36:1101–1107. 2005. View Article : Google Scholar : PubMed/NCBI
22	Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, et al: Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology. 129:1454–1463. 2005. View Article : Google Scholar : PubMed/NCBI
23	Unoki M, Kelly JD, Neal DE, Ponder BA, Nakamura Y and Hamamoto R: UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. Br J Cancer. 101:98–105. 2009. View Article : Google Scholar : PubMed/NCBI
24	Wu TF, Zhang W, Su ZP, et al: UHRF2 mRNA expression is low in malignant glioma but silencing inhibits the growth of U251 glioma cells in vitro. Asian Pac J Cancer Prev. 13:5137–5142. 2012. View Article : Google Scholar : PubMed/NCBI
25	Sun Y: E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia. 8:645–654. 2006. View Article : Google Scholar : PubMed/NCBI
26	Ma C, Rong Y, Radiloff DR, et al: Extracellular matrix protein βig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev. 22:308–321. 2008.